Results

Total Results: 1,402 records

Showing results for "question".

161. Archived: Final Evidence Review: Testicular Cancer: Screening February 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review95/testicular-cancer-screening-february-2004
     February 15, 2004 - Questions and Results Key Question … Key Question 2: Is there evidence of harms associated with screening for this disease?

162. New Topic | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/public-comments-and-nominations/nominating-recommendation-statement-topics/new-topic
     March 16, 2025 - Privacy Policy View our Privacy Policy (new window) CAPTCHA This question

163. Research Gaps for Interventions to Prevent Falls in Community-Dwelling Older Adults: Evidence Gaps Research Taxonomy Table (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/-YHCmR_8bdShSaMTx6Mrgx
     May 23, 2024 - Abbreviations: CQ=contextual question; KQ=key question; N/A=not applicable; RCT=randomized, controlled

164. Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: Evidence Report and Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/U8LgX3tsN9LEF5JnsNbSc_
     September 13, 2022 - Benefits of Screening Key Question 1. … No eligible studies addressed this question. Harms of Screening Key Question 2. … No eligible studies addressed this question. Benefits of Interventions Key Question 3a. … Key Question 3b. … Key Question 3c.

165. Evidence Summary: Bladder Cancer in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary14/bladder-cancer-in-adults-screening
     October 15, 2010 - We assessed the overall strength of the body of evidence for each key question (good, fair, or poor) … (Key Question 1) We identified no RCTs of screening for bladder cancer. … (Key Question 2) No study evaluated the sensitivity and specificity of screening tests for bladder … KQ . key question; RCT . randomized, controlled trial. … Arrow 4 represents Key Question 4: "What are the harms of screening for bladder cancer and treatment

166. Evidence Summary: Thyroid Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/thyroid-cancer-screening
     May 09, 2017 - Screening Effectiveness or Accuracy Key Question 1. … Benefits of Treatment Key Question 4. … Harms of Treatment Key Question 5. … 3 studies of screening harms (Key Question 3), 2 studies of treatment benefits (Key Question 4), and … 52 studies of treatment harms (Key Question 5).

167. Final Research Plan: Cervical Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cervical-cancer-screening-adults-adolescents
     March 17, 2022 - intraepithelial neoplasia grade 3; HPV=human papillomavirus; hrHPV=high-risk human papillomavirus; KQ=key question … comment, the USPSTF included pregnant persons in the population of interest and added a contextual question

168. Final Research Plan: Prevention of Acquisition of HIV: Preexposure Prophylaxis | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
     January 13, 2022 - Abbreviations: FTC=emtricitabine; HIV=human immunodeficiency virus; KQ=key question; PrEP=pre-exposure … hepatitis B as an outcome, added “persistence” to Contextual Questions 1 and 2, and expanded Contextual Question

169. Evidence Summary: Pancreatic Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/pancreatic-cancer-screening
     August 06, 2019 - Effectiveness of Screening Key Question 1. … Key Question 1a. … Key Question 2. … Harms of Screening Key Question 3. … Harms of Treatment Key Question 5.

170. Evidence Summary: Lung Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary14/lung-cancer-screening
     March 09, 2021 - Key Question 1b. … Key Question 1c. … Key Question 1d. … Key Question 3b. … Key Question 3c.

171. Screening for Idiopathic Scoliosis in Adolescents: A Brief Evidence Update (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/tBNG587psNsCn7HHcfRuqm
     November 01, 2004 - Studies were excluded if they did not meet the specific inclusion criteria or were not relevant to a key question … Only 16 articles directly addressed a critical key question, and only 1 was an RCT. … No studies addressing this question were identified. 2. … We found only 1 RCT that addressed this critical key question. … A summary of cohort studies and case series analyses that address this critical key question follows.

172. JAMA JATS (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/pKa4_DYwzuyD6RDgYzLMbo
     August 22, 2018 - Benefits of Screening for IPV Key Question 1. … Accuracy of Screening for IPV Key Question 2. … Harms of Screening for IPV Key Question 3. … Harms of Interventions Key Question 5. … STaT: a three-question screen for intimate partner violence.

173. Archived: Final Evidence Summary: Depression in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary20/depression-in-adults-screening-2009
     December 15, 2009 - Search results and article flow, by key question Appendix Table 2. … Key question 1 trials compared outcomes in screened and unscreened patients. … KQ = key question. *Go to full report for other KQ criteria 16 . … At the top of the figure is a circle with a "1" in it for key question 1. … KQ = key question

174. Draft Research Plan: Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Falls and Fractures in Community-Dwelling Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/vitamin-d-calcium-combined-supplementation-primary-prevention-falls-fractures-communitydwelling-adults
     January 12, 2023 - Abbreviation: KQ=key question. … Abbreviations: BMD=bone mineral density; ED=emergency department; KQ=key question; RCT=randomized, controlled

175. Archived: Evidence Summary: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary10/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication
     March 15, 2009 - Data Synthesis We synthesized the studies qualitatively and organized them by key question. … Key Question 2 Does aspirin use in women and men increase gastrointestinal bleeding or hemorrhagic … Four studies provided information on the harms of aspirin for this key question. … The upper arrow is labeled "KQ1" for "Key Question 1." … The lower arrow pointing from the first rectangle is labeled "KQ2" for "Key Question 2."

176. Archived: Evidence Summary: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary10/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication-2009
     March 15, 2009 - Data Synthesis We synthesized the studies qualitatively and organized them by key question. … Key Question 2 Does aspirin use in women and men increase gastrointestinal bleeding or hemorrhagic … Four studies provided information on the harms of aspirin for this key question. … The upper arrow is labeled "KQ1" for "Key Question 1." … The lower arrow pointing from the first rectangle is labeled "KQ2" for "Key Question 2."

177. Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication
     November 13, 2016 - Key Question 1b. … Key Question 1c. … 1a, 0 trials (direct evidence) for Key Question 1b, 7 trials for Key Question 1c, 17 trials and 2 observational … studies for Key Question 2, and 3 trials (direct evidence) for Key Question 3. … Quality: See key question 1a Estimates precise Poor Key Question 1c: Subgroups 7 RCTs

178. Archived: Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication-november-2016
     November 13, 2016 - Key Question 1b. … Key Question 1c. … 1a, 0 trials (direct evidence) for Key Question 1b, 7 trials for Key Question 1c, 17 trials and 2 observational … studies for Key Question 2, and 3 trials (direct evidence) for Key Question 3. … Quality: See key question 1a Estimates precise Poor Key Question 1c: Subgroups 7 RCTs

179. Archived: Final Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary4/colorectal-cancer-screening-2008
     October 15, 2008 - Eligibility Criteria for Studies, by Key Question Appendix Table 2. U.S. … Evidence tables and tables of excluded studies for each key question are available in the full report … (Key question 2b) Fecal tests 11 total studies FIT Internal —Fair. … (Key question 2a) Colonoscopy Internal —Fair. External —Fair to poor. … (Key question 3a) Colonoscopy Internal —Fair. External —Good.

180. Final Research Plan: Hepatitis C Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/hepatitis-c-screening
     December 21, 2017 - transmission (KQ 5), harms of treatment (KQ 7); behavioral outcomes will be included for Contextual Question … reports, studies not reporting original data Abbreviation s: HCV=hepatitis C virus; KQ=key question … The USPSTF also added a KQ on the yield of repeat HCV screening and revised Contextual Question 3 to